(Q72105922)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

María-Belén Vidriales

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Marcos González Díaz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

Jesus Maria Hernandez Rivas

23 October 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Jesús San Miguel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

2

A Orfao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

author name string

M C López-Berges

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

J Ciudad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A López

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

M J Moro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

M Martínez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 November 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

217-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

Cytotoxicity of purified leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia

23 October 2019

cites work

1 reference

12 December 2020

T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia

1 reference

12 December 2020

Biology and clinical relevance of human natural killer cells

1 reference

12 December 2020

The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma

1 reference

12 December 2020

Production of tumour-derived suppressor factor in patients with acute myeloid leukaemia

1 reference

12 December 2020

Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease

1 reference

12 December 2020

Resistance of leukemic blasts to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties

1 reference

12 December 2020

Loss of natural killer activity as an indicator of relapse in acute leukaemia

1 reference

12 December 2020

Natural killer cell-mediated inhibition of growth of myeloid and lymphoid clonogenic leukemias

1 reference

12 December 2020

Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics.

1 reference

12 December 2020

Comparative studies of human FcRIII-positive and negative natural killer cells

1 reference

12 December 2020

Differential lysis of melanoma clones by autologous recombinant interleukin 2-activated lymphocytes. Relationship with spontaneous resistance to doxorubicin (Dx).

1 reference

12 December 2020

Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.

1 reference

12 December 2020

Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission.

1 reference

12 December 2020

Evidence for three types of human cytotoxic lymphocyte

1 reference

12 December 2020

Immunodeficiency and the role of suppressor cells after human bone marrow transplantation

1 reference

12 December 2020

Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission.

1 reference

12 December 2020

Highly oncolytic adherent lymphocytes: therapeutic relevance for leukemia

1 reference

12 December 2020

Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission

1 reference

12 December 2020

Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission

1 reference

12 December 2020

Prognostic value of immunological markers in acute myeloblastic leukemia

1 reference

12 December 2020

A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells

1 reference

12 December 2020

Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance

1 reference

12 December 2020

Increased expression of natural-killer-associated and activation antigens in multiple myeloma

1 reference

12 December 2020

Natural killer cells: definition of a cell type rather than a function

1 reference

12 December 2020

MHC restricted and non-restricted killer lymphocytes

1 reference

12 December 2020

Determination of T lymphocyte subpopulations in malignant lymphoproliferative diseases

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

1 reference

12 December 2020

Generation of cytotoxic NK cells in peripheral blood and bone marrow of patients with acute myelogenous leukemia after continuous infusion with recombinant interleukin-2.

1 reference

12 December 2020

Human NK cells in health and disease: clinical, functional, phenotypic and DNA genotypic characteristics

1 reference

12 December 2020

Decrease in number of CD16(LEU 11)+CD45RA(2H4)+ cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis

1 reference

12 December 2020

Are lymphokine activated killer cells a possible form of leukaemia immunotherapy?

1 reference

12 December 2020

Lymphokine-activated killer cytotoxicity against leukaemic blast cells

1 reference

12 December 2020

Altered natural killer cell activity in childhood acute non-lymphoid leukaemia. Augmented natural killer cell activity and cells expressing the Leu 7 and Leu 11b (CD 16) markers in the bone marrow of children in remission

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01715050

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7694663%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference